*Transforming Multiple Myeloma Treatment: The Promise of Novel Drug Classes* Multiple Myeloma, a hematologic malignancy characterized by the proliferation of malignant plasma cells in the bone marrow, has long been a challenging condition to manage. Despite advancements in treatment, the prognosis for multiple myeloma remains variable, and the need for innovative therapies is critical. For More https://www.delveinsight.com/blog/multiple-myeloma-treatment